FibroBiologics, Inc. Common StockFBLGNASDAQ
Loading
Operating Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+53.6%
5Y CAGR+69.1%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+53.6%/yr
Annual compound
5Y CAGR
+69.1%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
13.8x
Strong expansion
Streak
5 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $16.18M | +17.8% |
| 2024 | $13.74M | +54.5% |
| 2023 | $8.89M | +99.0% |
| 2022 | $4.47M | +183.1% |
| 2021 | $1.58M | +35.0% |
| 2020 | $1.17M | - |